Arsenic species excretion after dimercaptopropanesulfonic acid (DMPS) treatment of an acute arsenic trioxide poisoning

Archives of Toxicology

Volumn 77, Issue 2, 2003, Pages 63-68

  Heinrich Ramm, R ^a   Schaller, K H ^b   Horn, J ^c   Angerer, J ^b  

^a Zentralinstitut fur Arbeitsmedizin der Deutschen Demokratischen Republik   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c KLINIKUM NÜRNBERG   (Germany)

Author keywords

Antidote therapy; Arsenic intoxication; Dimercaptopropanesulfonic acid (DMPS); Urinary arsenic species

Indexed keywords

ARSENIC TRIOXIDE; CACODYLIC ACID; METHANEARSONIC ACID; METHYLTRANSFERASE; UNITHIOL;

ADULT; ARSENIC POISONING; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CASE REPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; ION EXCHANGE CHROMATOGRAPHY; MALE; METHYLATION; PRIORITY JOURNAL; URINARY EXCRETION; URINE LEVEL; URODYNAMICS;

EID: 0037291704     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-002-0413-z     Document Type: Article

References (22)

1. Aposhian HV (1998) Mobilization of mercury and arsenic in humans by sodium 2,3-dimercapto-1-propane sulfonate (DMPS). Environ Health Perspect 106:1017-1025
2. Aposhian HV, Carter DE, Hoover TD, Hsu CA, Maiorino RM, Stine E (1984) DMSA, DMPS, and DMPA - as arsenic antidotes. Fundam Appl Toxicol 4:58-70
3. Blythe D, Joyce DA (2001) Clearance of arsenic by haemodialysis after acute poisoning with arsenic trioxide. Intensive Care Med 27:334
4. De Kimpe J, Cornelis R, Vanholder R (1999) In vitro methylation of arsenite by rabbit liver cytosol: effect of metal ions, metal chelation agents, methyltransferase inhibitors and uremic toxins. Drug Chem Toxicol 22:613-628
5. Del Razo LM, Aguilar C, Sierra-Santoyo A, Cebrian ME (1999) Interference in the quantitation of methylated arsenic species in human urine. J Anal Toxicol 23:103-107
6. Feldmann J, Lai VW-M, Cullen WR, Ma M, Lu X, Le XC (1999) Sample preparation and storage can change arsenic speciation in urine. Clin Chem 45:1988-1997
7. Foa V, Colombi A, Maroni M (1984) The speciation of the chemical forms of arsenic in the biological monitoring of exposure to inorganic arsenic. Sci Tot Environ 34:241-2594
8. Heinrich-Ramm R, Mindt-Prüfert S, Szadkowski D (2001) Arsenic species excretion in a group of persons in northern Germany - contribution to the evaluation of reference values. Int J Hyg Environ Health 203:475-477
9. Heinrich-Ramm R, Mindt-Prüfert S, Szadkowski D (2002) Arsenic species excretion after controlled seafood consumption. J Chromatogr B Special issue: Analytical chemistry in occupational and environmental medicine (in press)
10. Horn J, Eicher H, Mühlberg W, Platt D (2002) Akute Arsentrioxid-Intoxikation - blander Verlauf nach hochdosierter Chelat-Therapie. Intensivmedizin und Notfallmedizin 39:246-253
11. Hurlbut KM, Maiorino RM, Mayersohn M, Dart RC, Bruce DC, Aposhina HV (1994) Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers. J Pharmacol Exp Ther 268:662-668
12. Kruszewska S, Wiese M, Kolacinski Z, Mielczarska J (1996) The use of haemodialysis and 2,3-propanesulphonate (DMPS) to manage acute oral poisoning by lethal dose of arsenic trioxide. Int J Occup Med Environ Health 9:111-115
13. Lauwerys RR, Hoet P (eds) (1993) Industrial chemical exposure - guidelines for biological monitoring, 2nd edn. Lewis, Boca Raton Florida
14. Lehnert G, Schaller KH, Angerer J (1999) Report on the status of the external quality control programs for occupational-medical and environmental-medical toxicological analyses in biological materials in Germany. Int Arch Occup Environ Health 72:60-64
15. Lovell MA, Farmer JG (1985) Arsenic speciation in urine from humans intoxicated by inorganic arsenic compounds. Hum Toxicol 4:203-214
16. Maiorino RM, Aposhian HV (1985) Dimercaptan metal-binding agents influence the biotrasformation for arsenite in the rabbit. Toxicol Appl Pharmacol 77:240-250
17. Moore DF, O'Callaghan CA, Berlyne G, Ogg CS, Davies HA, House IM, Henry JA (1994) Acute arsenic poisoning: absence of polyneuropathy after treatment with 2,3-dimercaptopropanesulphonate (DMPS). J Neurol Neurosurg Psychiatry 57:1133-1135
18. Muckter H, Liebl B, Reichl FX, Hunder G, Walther U, Fichtl B (1997) Are we ready to replace dimercaprol (BAL) as an arsenic antidote? Hum Exp Toxicol 16:460-465
19. III) is more toxic than arsenite in Chang human hepatocytes. Toxicol Appl Pharmacol 163:203-207
20. Schaller KH, Angerer J, Drexler H (2002) Quality assurance of biological monitoring in occupational and environmental medicine. J Chromatogr B (in press)
21. Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, Reed W, Wang C, Cullen WR, Thomas DJ (2000) Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol 74:289-299
22. Wax PM, Thornton CA (2000) Recovery from severe arsenic-induced peripheral neuropathy with 2,3-dimercapto-1-propane-sulphonic acid. J Toxicol Clin Toxicol 38:777-780